Practice Location

1302 PENNSYLVANIA AVE
HAGERSTOWN, MD 21742-3108

Phone: (240) 313-3200

What does MARK JAMESON research?

Dr. Jameson studies various aspects of cancer treatment and immune responses. He investigates how treatments like radiation therapy can be more effective using new technologies, such as Kilovoltage Intrafraction Monitoring and the MR-Linac machine. His work also explores the immune system, particularly how CD8 T cells respond to infections like tuberculosis, aiming to find ways to enhance patient therapy outcomes. Beyond cancer, Dr. Jameson examines communication between autistic and non-autistic individuals to identify strengths and improve mutual understanding.

Key findings

  • Removing the NR4A1 protein in mice with tuberculosis led to a significant immune response improvement, resulting in lower bacterial levels and 80% increased activated CD8 T cells.
  • In a study on prostate cancer, rectal spacers during therapy significantly reduced rectal radiation exposure without increasing side effects.
  • For pancreatic cancer, a treatment with LSTA1 combined with existing therapies achieved a 92% disease control rate within 16 weeks.
  • Using new imaging techniques during radiation therapy for head and neck cancer showed that patients with favorable imaging responses had a 0% recurrence rate after one year, compared to 78% for unfavorable responses.
  • Over two years, 70.6% of brain metastases patients treated with hypo-fractionated radiotherapy did not experience a return of cancer in the treated area.

Frequently asked questions

Does Dr. Jameson study tuberculosis?
Yes, he studies how immune responses can be enhanced in tuberculosis patients, focusing on specific proteins like NR4A1.
What treatments has Dr. Jameson researched?
He has researched various cancer treatments, including innovative radiation therapies and combination treatments for pancreatic cancer.
Is Dr. Jameson's work relevant to patients with prostate cancer?
Yes, he investigates new technologies in radiation therapy that can improve treatment precision and patient safety for prostate cancer.
How does Dr. Jameson's research benefit autistic individuals?
His research enhances understanding of communication strengths among autistic individuals, promoting better communication strategies.
What is the significance of Dr. Jameson's work on imaging in cancer treatment?
His studies indicate that imaging changes during treatment can accurately predict patient outcomes, thereby guiding more effective treatment protocols.

Publications in plain English

The Kilovoltage Intrafraction Monitoring Real-Time Prostate Cancer Image Guided Radiation Therapy Technology Journey: From Clinical Trials to Your Clinic.

2026

International journal of radiation oncology, biology, physics

Keall PJ, Booth J, Eade T, Hewson EA, Kishan AU +10 more

Plain English
This paper discusses a new technology called Kilovoltage Intrafraction Monitoring (KIM) that improves the treatment of prostate cancer using Radiation Therapy. The study found that KIM provided very accurate treatment delivery, with submillimeter precision, helping doctors adjust for any movement during the procedure, which can happen in real-time. The advancements made through KIM make it easier and safer for patients to receive effective stereotactic body radiation therapy, aiming to improve treatment outcomes. Who this helps: This helps prostate cancer patients and their doctors.

PubMed

NR4A1 limits CD8T Cell effector responses and protection in tuberculosis.

2026

Research square

Fatima S, Chen Y, Smulan L, Satish B, Jameson M +9 more

Plain English
This study investigated how a protein called NR4A1 affects CD8T cells, which are crucial for fighting tuberculosis (TB). Researchers found that when NR4A1 was removed, mice had fewer bacteria and better immune responses, with more active CD8T cells in their lungs. Specifically, these mice had less lung damage and higher levels of CD8T cells, suggesting that targeting NR4A1 could help improve TB treatments. Who this helps: This helps patients with tuberculosis by potentially leading to more effective therapies.

PubMed

NR4A1 limits CD8⁺ T Cell effector responses and protection in tuberculosis.

2026

bioRxiv : the preprint server for biology

Fatima S, Chen Y, Smulan L, Satish B, Jameson M +9 more

Plain English
This study investigated the role of a protein called NR4A1 in CD8⁺ T cells during tuberculosis (TB) infection. Researchers found that when NR4A1 was removed in mice, these cells had stronger immune responses, leading to lower bacterial levels and less lung damage, with a significant increase in activated CD8 T cells. This is important because it suggests that targeting NR4A1 could improve immune responses and treatment outcomes for TB patients. Who this helps: This helps TB patients by potentially enhancing their immune response to the infection.

PubMed

Dosimetric impact of variable air cavity within PTV for rectum cancer.

2025

Journal of applied clinical medical physics

Chan E, Goodall SK, Finnegan R, Moorfoot P, Jameson M +1 more

Plain English
This study looked at how changes in the amount of air in the rectum affect the quality of treatment plans for patients with rectal cancer. Researchers found that when air volume exceeded 17 cubic centimeters, the coverage of the targeted treatment area decreased by about 10.8%, meaning less of the cancer was being effectively treated. This is important because ensuring sufficient treatment coverage can improve patient outcomes, and the study provides guidelines for doctors on acceptable levels of rectal air during radiation therapy. Who this helps: This helps patients with rectal cancer and their doctors by providing better treatment planning guidelines.

PubMed

Improving patient specific quality assurance for image registration: clinical use case of target contouring for PET deformable image registration.

2025

Physical and engineering sciences in medicine

Yuen J, Poder J, Jameson M, Schmidt L, Brown R +4 more

Plain English
This study focused on making sure the images used in radiation treatment are accurate by improving the quality checks for a method called deformable image registration (DIR). Researchers created a better process for checking the accuracy of images and target areas in treatment planning, specifically addressing problems found when using DIR. Their new approach has the potential to enhance image accuracy and patient safety, helping medical teams avoid mistakes in treatment decisions. Who this helps: This benefits patients receiving radiation therapy by ensuring more precise treatment targeting.

PubMed

Hypo-Fractionated Radiotherapy to the Cavity for Resected Brain Metastases: A UK Series.

2025

Clinical oncology (Royal College of Radiologists (Great Britain))

Barker CL, Shane T, Hodgson C, Jameson M, King J +4 more

Plain English
This study looked at a new type of radiation therapy for patients who had surgery to remove cancer that had spread to the brain. After treating 65 patients with a specific radiation dose, the researchers found that after two years, about 70.6% of them had not experienced a return of cancer in the treated area. This matters because it shows that this type of radiation therapy can effectively control cancer growth after surgery while having a low risk of serious side effects. Who this helps: This helps patients recovering from brain metastases surgery.

PubMed

TrackRAD2025 challenge dataset: real-time tumor tracking for MRI-guided radiotherapy.

2025

Medical physics

Wang Y, Lombardo E, Thummerer A, Blöcker T, Fan Y +23 more

Plain English
This study focused on creating a large dataset of MRI scans from cancer patients undergoing treatment, specifically using machines that combine MRI and radiation therapy. The dataset includes 20,543 images from 585 patients across six hospitals and includes detailed annotations for some cases. This information will help researchers develop better ways to track tumors in real-time, which can improve the safety and effectiveness of cancer treatments. Who this helps: This benefits patients receiving radiotherapy, as they may experience more accurate treatments.

PubMed

Mutual Understanding: The Role of Neurotype-Matching and Perceptions in Communication Effectiveness.

2025

American journal of speech-language pathology

Jameson M, Bean A

Plain English
This study examined how well autistic and non-autistic adults communicate with each other, comparing pairs with the same neurotype to those with different neurotypes. The results showed that pairs with matched neurotypes, particularly autistic pairs, were more accurate in their communication but took longer to complete tasks. This matters because it highlights that when people share similar brain styles, they tend to understand each other better, emphasizing the need for tailored communication approaches. Who this helps: This helps patients and their caregivers by improving communication strategies.

PubMed

Implications of Linguistic Convergence and Divergence Among Matched and Mixed Autistic and Non-Autistic Communication Partners.

2025

Journal of speech, language, and hearing research : JSLHR

Jameson M, Bean A

Plain English
This study looked at how autistic and non-autistic people communicate with each other and whether they become more similar in their language over time. Researchers found that pairs of autistic individuals developed stronger similarities in their speech throughout their conversations, which helped them build better connections with each other. Interestingly, when autistic and non-autistic individuals communicated together, they often became less aligned in their language. These findings highlight that autistic individuals have specific strengths in communication, especially when they talk to other autistic peers, which can enhance mutual understanding. Who this helps: This helps autistic adults by recognizing their strengths in communication with each other.

PubMed

Evaluating the relationship between contouring variability and modelled treatment outcome for prostate bed radiotherapy.

2024

Physics in medicine and biology

Le Bao V, Haworth A, Dowling J, Walker A, Arumugam S +8 more

Plain English
This study looked at how differences in the way prostate bed areas are outlined (contoured) for radiation therapy affect treatment outcomes. Researchers examined data from 10 patients and found that slight variations (less than 5 mm) in these outlines led to only minor changes in the dose of radiation given, particularly related to rectum toxicity. This is important because it shows that some degree of variability in outlining may not significantly impact treatment, helping to reduce the need for overly precise contouring. Who this helps: This helps patients undergoing post-prostatectomy radiotherapy by potentially simplifying treatment planning.

PubMed

The impact of rectal spacers in MR-guided adaptive radiotherapy.

2024

Clinical and translational radiation oncology

Batumalai V, Crawford D, Picton M, Tran C, Jelen U +3 more

Plain English
This study looked at the use of rectal spacers during a specific type of radiotherapy for prostate cancer, called MR-guided adaptive radiotherapy (MRgART). Researchers found that patients with rectal spacers had significantly lower rectal radiation exposure, while both groups showed similar levels of side effects—none had severe gastrointestinal problems. This is important because it means rectal spacers can help protect patients' rectal health during treatment without increasing side effects. Who this helps: Patients undergoing radiation therapy for prostate cancer.

PubMed

Process of development of decentralised clinical trial methodology for cancer clinical trials in Aotearoa New Zealand.

2024

The New Zealand medical journal

Lawrence NJ, Laing BB, Tyro J, Babington S, Dzhelali M +12 more

Plain English
This study focused on creating new ways to conduct cancer clinical trials in New Zealand that are fair and accessible for everyone, especially Māori, Pacific communities, vulnerable groups, and those living in rural areas. Researchers developed 12 procedures to guide these trials, which allow patients to participate without having to travel far, keeping them close to family and local medical teams. This approach can improve access to clinical trials and enhance the quality of care for participants. Who this helps: This benefits cancer patients and their families, particularly those from underserved communities.

PubMed

Old dogs, new tricks: MR-Linac training and credentialing of radiation oncologists, radiation therapists and medical physicists.

2023

Journal of medical radiation sciences

Hogan L, Jameson M, Crawford D, Alvares S, Loo C +8 more

Plain English
Researchers studied how to train and certify radiation oncologists, radiation therapists, and medical physicists in using new MR-Linacs, which are advanced machines that improve cancer treatment. They found that proper training is crucial for these professionals to safely and effectively use MR technology in their work. This matters because it ensures better treatment outcomes for patients by improving the quality of care and safety in radiation therapy. Who this helps: Patients undergoing radiation treatment for cancer.

PubMed

Introduction of radiation therapist-led adaptive treatments on a 1.5 T MR-Linac.

2023

Journal of medical radiation sciences

Picton M, Crawford D, Jameson M, Alvares S, Hogan L +8 more

Plain English
This study looked at how radiation therapists can lead treatments using a new type of machine called the MR-Linac, which combines magnetic resonance imaging with radiation therapy. Researchers found that having radiation therapists in charge of the process made treatments easier and better organized, helping to optimize the use of this advanced technology. This matters because it can potentially speed up treatment times and improve care for patients receiving radiation therapy. Who this helps: This benefits patients undergoing radiation therapy for cancer.

PubMed

MR-Linac guided adaptive stereotactic ablative body radiotherapy for recurrent cardiac sarcoma with mitral valve bioprosthesis - a case report.

2023

Journal of medical radiation sciences

Batumalai V, Carr M, Jameson M, Crawford D, Jelen U +4 more

Plain English
This study followed a 78-year-old woman with a type of heart cancer called recurrent cardiac sarcoma, located near her artificial mitral valve. Using a specialized machine called an MR-Linac, doctors delivered a precise radiation treatment, targeting her tumor while avoiding damage to the surrounding tissues. The treatment was effective, with the tumor remaining stable and the patient reporting good symptom relief without any immediate side effects. Who this helps: This helps patients with recurrent cardiac sarcoma, especially those with heart valve replacements.

PubMed

Changes in serial multiparametric MRI and FDG-PET/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer.

2023

European radiology

Trada Y, Keall P, Jameson M, Moses D, Lin P +6 more

Plain English
This study looked at whether changes in specific types of imaging (MRI and PET scans) during radiation therapy could help predict how well patients with head and neck cancer would respond to treatment. Researchers analyzed data from 55 patients and found that by the third week of treatment, certain imaging changes—specifically in the ADC from MRI and metabolic tumor volume from PET scans—were strong indicators of the likelihood of cancer returning after one year. For example, patients with a favorable imaging response had a 0% recurrence rate, compared to a 78% recurrence rate in those with an unfavorable response. Who this helps: This research benefits patients with head and neck cancer by providing more accurate predictions of treatment outcomes.

PubMed

Optimising the MR-Linac as a standard treatment modality.

2023

Journal of medical radiation sciences

de Leon J, Twentyman T, Carr M, Jameson M, Batumalai V

Plain English
This study focused on the use of a new type of cancer treatment device called the MR-Linac, which helps doctors see tumors and surrounding organs more clearly during radiation therapy. The researchers found that using this technology led to less uncertainty in treatment but also required more time and resources. Improving how the MR-Linac is used can make cancer treatment more effective and efficient in busy hospitals, which is important for patient care. Who this helps: Patients undergoing radiation therapy.

PubMed

ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial.

2023

ESMO gastrointestinal oncology

Lee J, Dean A, Price T, Sjoquist K, Gebski V +25 more

Plain English
This study tested a new treatment called LSTA1, combined with gemcitabine and nab-paclitaxel, for patients with untreated advanced pancreatic cancer. Researchers found that the treatment could improve disease control, with a previous trial showing a 92% control rate at 16 weeks. This matters because pancreatic cancer is very difficult to treat, and new strategies could lead to better outcomes for patients. Who this helps: Patients with metastatic pancreatic cancer.

PubMed

Automated post-operative brain tumour segmentation: A deep learning model based on transfer learning from pre-operative images.

2022

Magnetic resonance imaging

Ghaffari M, Samarasinghe G, Jameson M, Aly F, Holloway L +4 more

Plain English
This study focused on developing an automated system to identify and outline different parts of brain tumors in post-surgery images. Researchers tested their new method on brain scans from 15 patients who had received radiation therapy, achieving high accuracy with scores of 0.83 for whole tumors, 0.77 for the tumor core, and 0.60 for the most active part of the tumor. These findings are important because they could help doctors more accurately analyze and monitor brain tumors after surgery, potentially improving patient care. Who this helps: This helps patients undergoing treatment for brain tumors and their doctors.

PubMed

Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial.

2022

Clinical cancer research : an official journal of the American Association for Cancer Research

Cohen EEW, Nabell L, Wong DJ, Day T, Daniels GA +15 more

Plain English
This study looked at how well a treatment combining SD-101 and pembrolizumab worked for patients with a type of head and neck cancer who hadn’t had prior anti-PD-1 therapy. Out of 51 patients, 24% showed a positive response to the treatment, with older women benefiting the most, particularly those with HPV-positive tumors at a rate of 44%. The study is significant because it suggests that this combination therapy can effectively shrink tumors and boost the body’s immune response against cancer. Who this helps: Patients with head and neck cancer, especially those with HPV-positive tumors.

PubMed

MIRSIG position paper: the use of image registration and fusion algorithms in radiotherapy.

2022

Physical and engineering sciences in medicine

Lowther N, Louwe R, Yuen J, Hardcastle N, Yeo A +2 more

Plain English
This paper examines how advanced imaging techniques can improve radiotherapy, specifically focusing on how to effectively combine and align images (known as image registration and fusion) for better treatment planning. The group behind this paper, MIRSIG, agrees with earlier recommendations from another report, and it offers new guidelines for using these advanced tools to improve patient outcomes. This matters because better imaging can lead to more accurate targeting of tumors, enhancing treatment effectiveness and minimizing damage to healthy tissues. Who this helps: This helps patients undergoing radiotherapy and the doctors treating them.

PubMed

Segmental Cardiac Radiation Dose Determines Magnitude of Regional Cardiac Dysfunction.

2021

Journal of the American Heart Association

Trivedi SJ, Tang S, Byth K, Stefani L, Lo Q +8 more

Plain English
This study looked at how radiation used to treat left-sided breast cancer affects the heart in women who have not yet had chemotherapy. Researchers found that the parts of the heart that received the highest doses of radiation, especially the apex and anterior wall, showed a significant decline in function six weeks after treatment, and this decline persisted after a year. This is important because it highlights how radiation can harm the heart, potentially adding to problems caused by chemotherapy. Who this helps: Patients with left-sided breast cancer undergoing radiation therapy.

PubMed

Kratom-induced transaminitis with subsequent precipitated opioid withdrawal following naltrexone.

2021

The mental health clinician

Jensen AN, Truong QN, Jameson M, Nadal CN

Plain English
This study looked at a case where a person using kratom, an herbal supplement popular for pain relief and recreational use, developed liver inflammation and experienced sudden opioid withdrawal after being treated with naltrexone, a medication that blocks opioid effects. The case highlights significant health risks associated with kratom, including potential liver damage, especially when combined with other treatments. Understanding these risks is crucial for ensuring patient safety and monitoring drug interactions effectively. Who this helps: This information benefits patients using kratom and healthcare providers managing their treatment.

PubMed

Machine learning applications in radiation oncology.

2021

Physics and imaging in radiation oncology

Field M, Hardcastle N, Jameson M, Aherne N, Holloway L

Plain English
This research paper examines how machine learning can improve radiation oncology, a field that treats cancer using radiation. Researchers found that using machine learning can make treatment processes more efficient, consistent, and ultimately improve patient outcomes, especially by standardizing data collection and integrating this technology into existing workflows. By investing in better data quality and collaboration among experts, patients can expect more effective and tailored radiation treatments. Who this helps: Patients undergoing radiation therapy.

PubMed

Deep learning for segmentation in radiation therapy planning: a review.

2021

Journal of medical imaging and radiation oncology

Samarasinghe G, Jameson M, Vinod S, Field M, Dowling J +2 more

Plain English
This paper reviews how deep learning technology, specifically a type called convolutional neural networks (CNN), is being used to help identify and outline organs during radiation therapy planning. The majority of studies focus on using a model called U-net to segment tissues, particularly in the head and neck area, with a growing number of research papers being published on this topic. By improving how organs are segmented, this technology can make radiation therapy more effective and reliable. Who this helps: Patients undergoing radiation therapy.

PubMed

Remote Skin Cancer Diagnosis: Adding Images to Electronic Referrals Is More Efficient Than Wait-Listing for a Nurse-Led Imaging Clinic.

2021

Cancers

Jones L, Jameson M, Oakley A

Plain English
This study looked at two ways for doctors to get advice on suspected skin cancers: one method involved sending patients to a nurse-led clinic, while the other required doctors to attach images of skin lesions to their referrals. Researchers found that using the image method (Suspected Skin Cancer pathway) led to a quicker response time, with an average wait of just 4 days, compared to 50 days for the nurse-led clinic. Both methods had similar accuracy in diagnosing whether lesions were cancerous, achieving about 70% agreement with lab tests. Who this helps: This benefits patients who need quick and reliable skin cancer assessments.

PubMed

Two Cases of Respiratory Insufficiency Secondary to Pre-procedural Nerve Blocks for Upper Extremity Injuries.

2021

Cureus

Patel NJ, Jameson M, Leonard M, Burns B

Plain English
This study looked at two patients who faced breathing problems after receiving nerve blocks (injections to relieve pain) before surgery on their arms. One patient had no known health issues, while the other was overweight and had possible sleep apnea. Both experienced respiratory distress, indicating that even patients without obvious risk factors can have serious complications from these procedures, emphasizing the need for better communication among healthcare teams to improve safety. Who this helps: This helps patients undergoing upper extremity surgery and their doctors.

PubMed

Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors.

2020

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Desai J, Gan H, Barrow C, Jameson M, Atkinson V +22 more

Plain English
This study tested a new drug called lifirafenib in patients with certain types of cancer that have specific gene mutations. They found that lifirafenib was safe to use at a dose of up to 40 mg per day and showed effectiveness, particularly in patients with melanoma and certain thyroid and ovarian cancers, with several patients experiencing significant improvements: one patient had a complete response and eight others had confirmed positive responses. This research is important because it highlights a potential new treatment option for patients with tumors that are difficult to treat, especially those with specific genetic mutations. Who this helps: This helps cancer patients with specific mutations, particularly those with melanoma, thyroid cancer, and low-grade serous ovarian cancer.

PubMed

Impact of dosimetric differences between CT and MRI derived target volumes for external beam cervical cancer radiotherapy.

2020

The British journal of radiology

Batumalai V, Burke S, Roach D, Lim K, Dinsdale G +5 more

Plain English
This study looked at how using MRI compared to CT affects the planning of radiation therapy for cervical cancer patients. Researchers found that while MRI led to lower doses of radiation to the bladder, the overall differences in radiation doses to other important organs were small. This matters because it helps doctors understand which imaging method might provide better protection to patients' organs while treating cervical cancer. Who this helps: This helps patients undergoing radiation therapy for cervical cancer.

PubMed

Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors.

2020

Journal for immunotherapy of cancer

Desai J, Deva S, Lee JS, Lin CC, Yen CJ +20 more

Plain English
This study looked at a new treatment called tislelizumab for patients with advanced solid tumors. Out of 451 patients tested, 18% in the initial phase and 12% in the later phase showed a positive response to the treatment, meaning their tumors shrank. The treatment was generally safe, with fatigue and nausea being the most common side effects, affecting about a quarter of the participants, but serious side effects were rare. Who this helps: Patients with advanced solid tumors.

PubMed

A Narrative Overview of Active Surveillance for Clinically Localised Prostate Cancer.

2020

Seminars in oncology nursing

Bates AS, Kostakopoulos N, Ayers J, Jameson M, Todd J +7 more

Plain English
This study looked at "active surveillance" (AS) as a way to manage low-risk localized prostate cancer instead of jumping straight to treatments like surgery or radiation, which can have serious side effects. The findings highlight that AS can effectively monitor patients without immediate treatment, helping avoid unnecessary procedures for many while still identifying those who may need more aggressive care later. This is important because it can improve patients' quality of life while ensuring that those at risk receive timely treatment. Who this helps: This helps patients with low-risk prostate cancer.

PubMed

Deforming to Best Practice: Key considerations for deformable image registration in radiotherapy.

2020

Journal of medical radiation sciences

Barber J, Yuen J, Jameson M, Schmidt L, Sykes J +10 more

Plain English
This paper looks at how deformable image registration (DIR) is used in radiation therapy to improve treatment planning and monitoring. It found that while DIR can enhance accuracy in patient treatment, there are still limitations and challenges that clinics face when adopting this technology, especially in Australia and New Zealand. The report provides guidance on best practices to help clinics implement DIR effectively, with recommendations in areas like training and quality assurance. Who this helps: This helps doctors and clinics in radiation therapy by improving their treatment techniques for patients.

PubMed

Examining Effects of Age on Outcomes after Nontraditional Motorized Vehicle Accidents.

2020

Cureus

Jameson M, Lawson C, Wheeler H, Leonard M, Quinn M +1 more

Plain English
This study looked at how age affects recovery after accidents involving nontraditional motorized vehicles, like all-terrain vehicles (ATVs). Researchers followed 558 patients aged 18 and older and found that the elderly group (65 years and older) had longer hospital stays and were more likely to need care after being discharged than younger adults. Overall, the mortality rate was 4.1%, with the majority of accidents involving ATVs, which caused 17 deaths. Who this helps: This information benefits elderly patients and healthcare providers by highlighting the need for tailored care for older adults in motorized vehicle accidents.

PubMed

Quantification of cardiac subvolume dosimetry using a 17 segment model of the left ventricle in breast cancer patients receiving tangential beam radiotherapy.

2019

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Tang S, Otton J, Holloway L, Delaney GP, Liney G +6 more

Plain English
This study looked at how radiation therapy for breast cancer affects different parts of the heart, specifically the left ventricle, in 29 patients. They found that the average radiation dose to the heart was 2.62 Gy, but some specific areas, like the apex of the heart, received much higher doses, up to 30.02 Gy. Understanding these differences in radiation exposure is important for tracking potential heart problems after treatment and improving heart health monitoring for breast cancer survivors. Who this helps: This helps patients recovering from breast cancer and their healthcare providers by improving cardiac care post-treatment.

PubMed

Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.

2019

Journal of medical imaging and radiation oncology

Cardoso M, Min M, Jameson M, Tang S, Rumley C +5 more

Plain English
This study investigated whether a special type of MRI called diffusion-weighted imaging (DWI) helps doctors more accurately identify the areas of head and neck cancer that need treatment during radiotherapy. Researchers found that when using DWI, the average size of the tumor volume they outlined was 13.37 cm³, compared to 10.92 cm³ when using just regular CT scanning, indicating that DWI might provide additional helpful information, although it only slightly changed how consistently different doctors agreed on the tumor outlines. This matters because better identification of cancer treatment areas can lead to more effective radiotherapy and potentially better outcomes for patients. Who this helps: This research benefits cancer patients undergoing head and neck radiotherapy.

PubMed

Investigating strategies to improve clinical trial opportunities for patients with cancer in New Zealand-INSIGHT.

2019

The New Zealand medical journal

So YJ, Jameson M, Newton V, O'Donnell A, Jeffery M +8 more

Plain English
This study looked at why so few adult cancer patients in New Zealand participate in clinical trials, finding that less than 5% actually do. Out of 691 surveyed patients, 86% indicated they would consider joining a trial, especially if it meant benefiting others or getting better treatment, though many were concerned about potential side effects and the additional time and cost involved. Understanding these factors is crucial because it can help improve access to clinical trials for cancer patients, leading to better treatment options. Who this helps: This helps cancer patients seeking better treatment options in clinical trials.

PubMed

A Multi-center Prospective Study for Implementation of an MRI-Only Prostate Treatment Planning Workflow.

2019

Frontiers in oncology

Greer P, Martin J, Sidhom M, Hunter P, Pichler P +14 more

Plain English
This study looked at whether it’s practical to plan prostate cancer treatment using only MRI scans instead of the usual CT scans. They found that all 25 patients in the trial successfully received treatment using the MRI-only approach, and the accuracy of the MRI plans was very high, with 99.7% of dose calculations matching the follow-up CT scans. This matters because it suggests that patients might receive high-quality treatment with less exposure to radiation compared to traditional methods. Who this helps: This helps prostate cancer patients by potentially improving their treatment planning and reducing unnecessary radiation exposure.

PubMed

Which near-patient tests might improve the diagnosis of UTI in older people in urgent care settings? A mapping review and consensus process.

2019

European geriatric medicine

Jameson M, Edmunds Otter M, Williams C, Modha D, Lim F +1 more

Plain English
This study looked at different tests that can quickly diagnose urinary tract infections (UTIs) in older patients at urgent care facilities. Researchers found 17 tests that may be useful for quick diagnosis, but most tests reviewed were not well-studied, and many had varying levels of accuracy. This is important because effective and rapid diagnosis can lead to better treatment outcomes for older patients who are more vulnerable to UTIs. Who this helps: This benefits older patients and healthcare providers in urgent care settings.

PubMed

Comparison of two tools to assess dyad feeding interaction in infants with gastroesophageal reflux disease.

2018

Journal for specialists in pediatric nursing : JSPN

Jameson M, Fehringer K, Neu M

Plain English
This study compared two tools used to evaluate how mothers and their infants interact during feeding, specifically for infants with gastroesophageal reflux disease (GERD). The researchers found that both tools identified feeding difficulties, with 83% of mother-infant pairs scoring below normal on one tool and 91% on the other. The study matters because it shows that using standardized tools can help healthcare providers pinpoint specific feeding issues and improve feeding interactions for better infant health. Who this helps: This benefits mothers, healthcare providers, and infants experiencing feeding challenges.

PubMed

Three-Year Results of a Medicare Advantage Cancer Management Program.

2018

Journal of oncology practice

Hoverman JR, Neubauer MA, Jameson M, Hayes JE, Eagye KJ +6 more

Plain English
This study looked at a program created by Texas Oncology and Aetna to improve cancer care for Medicare Advantage patients over three years. They found that the program saved over $3 million in total costs, with an average savings of about $1,874 per patient each month on medications. These savings came from better management of treatment plans and increased patient satisfaction, with 94% of patients reporting they were happy with the support services they received. Who this helps: This benefits older cancer patients by providing them with effective care while reducing treatment costs.

PubMed

The impact of contour variation on tumour control probability in anal cancer.

2018

Radiation oncology (London, England)

Jones MP, Martin J, Foo K, Estoesta P, Holloway L +1 more

Plain English
This study looked at how differences in outlining the tumor during treatment affect the success of radiation therapy for anal cancer. Researchers from nine Australian centers created treatment plans based on the same patient's scans and found that while there were some variations in the tumor control probability (TCP), these differences were not significant across the plans. Specifically, the TCP stayed consistent among treatments, but variations could become important if the tumor is larger or if a lower dose of radiation is used. Who this helps: This information benefits doctors treating anal cancer, as it shows that minor differences in tumor outlining may not drastically affect treatment outcomes.

PubMed

Comparison of four dimensional computed tomography and magnetic resonance imaging in abdominal radiotherapy planning.

2018

Physics and imaging in radiation oncology

Oar A, Liney G, Rai R, Deshpande S, Pan L +4 more

Plain English
This study looked at how well a new type of MRI, called four-dimensional MRI (4D-MRI), performs in comparison to the current standard, four-dimensional CT (4D-CT), for planning radiotherapy in patients with abdominal tumors. The results showed that 4D-MRI had an average motion error of 10.1 mm in patients, which was slightly better than 4D-CT's 11.2 mm, and 4D-MRI provided clearer images for important organs like the liver and kidneys. These findings are important because better imaging can lead to more accurate treatment planning and improved outcomes for patients undergoing radiotherapy. Who this helps: This helps patients with abdominal tumors and their doctors.

PubMed

Assessment of dose variation for accelerated partial-breast irradiation using rigid and deformable image registrations.

2017

Practical radiation oncology

Batumalai V, Holloway L, Walker A, Jameson M, Delaney GP

Plain English
This study looked at how different methods of measuring breast radiation treatment affect the actual dose delivered to both the targeted area and surrounding organs at risk, considering daily differences in patient positioning. It found that using deformable image registration led to an 18% increase in the average dose to the heart and a 28% increase to the opposite breast, while the target area received slightly less radiation. Understanding these variations is important for improving treatment accuracy and protecting healthy tissue during breast cancer therapy. Who this helps: This helps patients undergoing breast cancer treatment and their doctors by ensuring safer and more effective radiation therapy.

PubMed

Cutaneous melanoma: an audit of management timeliness against New Zealand guidelines.

2017

The New Zealand medical journal

Brian T, Adams B, Jameson M

Plain English
This study looked at how quickly patients with melanoma at Waikato Hospital received treatment according to New Zealand's cancer care guidelines. The results showed that compliance with these guidelines was very low, with some areas like referrals to first treatment having a compliance rate of only 0%, while the best rate was only 42.9% for confirmed cases. Improving the timeliness of melanoma care is important as it can lead to better outcomes for patients. Who this helps: This helps patients with melanoma who need timely treatment.

PubMed

Introduction.

2016

Maryland medicine : MM : a publication of MEDCHI, the Maryland State Medical Society

Jameson M

PubMed

Reflections on Value-Based Payment: The Latest Strategy in the Search for Cost-Cutting Miracles.

2016

Maryland medicine : MM : a publication of MEDCHI, the Maryland State Medical Society

Jameson M

PubMed

Effect of statin and aspirin use on toxicity and pathological complete response rate of neo-adjuvant chemoradiation for rectal cancer.

2016

Asia-Pacific journal of clinical oncology

Hardie C, Jung Y, Jameson M

Plain English
This study looked at how using statins and aspirin affects the side effects and treatment success for patients with rectal cancer undergoing radiation and chemotherapy before surgery. Out of 142 patients treated, only 13% had a complete response to the treatment, meaning their cancer could not be detected anymore. The researchers found that using statins or aspirin did not lower side effects or improve the success of the treatment compared to those who did not use these medications. Who this helps: This information is valuable for doctors and patients considering treatment options for rectal cancer.

PubMed

Determination of Biosolids Phosphorus Solubility and Its Relationship to Wastewater Treatment.

2016

Water environment research : a research publication of the Water Environment Federation

Jameson M, White JG, Osmond DL, Aziz T

Plain English
This study looked at different types of biosolids (treated sewage sludge) in North Carolina to understand how much phosphorus is soluble and can potentially pollute water sources. Researchers found that Class A alkaline biosolids had significantly less total phosphorus (5.0 g/kg) compared to other biosolids (26.6 g/kg), indicating that certain treatment methods greatly reduce the risk of pollution. This information is important because it will help guide the safe use of biosolids in agriculture and protect water quality. Who this helps: This helps farmers, environmental regulators, and communities near water sources.

PubMed

Pharmaceutical funding decisions must balance therapeutic innovation, opportunity costs and patient equity.

2016

The New Zealand medical journal

Ragupathy R, Jameson M

PubMed

Introduction.

2015

Maryland medicine : MM : a publication of MEDCHI, the Maryland State Medical Society

Jameson M, Rockower SJ

PubMed

Frequent Co-Authors

Lois Holloway Vikneswary Batumalai Jeremy de Leon David Crawford Tania Twentyman Jarad Martin Johnson Yuen Maddison Picton Urszula Jelen Madeline Carr

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.